论文部分内容阅读
【目的】探讨嗜铬细胞瘤的围手术期的治疗安全性。【方法】本文对１１ 例嗜 铬细胞瘤的临床治疗进行总结， 尤其对扩容 方法及术中、术 后血压管理 进行分析。【结果】９ 例 临床预 后良好，１ 例死亡，１ 例 放弃手 术。【结论】在围手术期治疗中，应根据临床分型选用血管活性药， 尤其是β－ 受体与钙通道阻滞剂的使用更为重要； 对症状不明显者 更应高度重视。
【Objective】 To investigate the perioperative therapeutic safety of pheochromocytoma. [Methods] This article summarized the clinical treatment of 11 cases of pheochromocytoma, especially the expansion method and the intraoperative and postoperative blood pressure management. [Results] 9 cases were clinically well-prepared, 1 died, and 1 gave up surgery. 【Conclusion】 In the perioperative treatment, vasoactive drugs should be selected according to the clinical classification. The use of β-receptors and calcium channel blockers is more important; more attention should be paid to those who do not have obvious symptoms.